In a devastating blow to investor confidence, Moderna’s shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
Healthcare9- Page
135Articles
The struggling consumer healthcare company Alliance Pharma appears poised to exit London’s junior stock exchange following a £350 million takeover bid from activist investor Dbay Advisors. The Isle of Man-based
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as
A landmark research initiative analysing blood proteins could catalyse significant advancements in disease treatment and prevention, presenting substantial opportunities for healthcare sector investors. The extensive UK-based study, backed by 14
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments.
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its